Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Destere

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
British Journal of Clinical Pharmacology|February 9, 2024
An artificial intelligence algorithm for co-clustering to help in pharmacovigilance before and during the COVID-19 pandemicAlexandre Destere, Giulia Marchello, Diane Merino, et al.
Clinical Pharmacokinetics|May 31, 2022
A Hybrid Model Associating Population Pharmacokinetics with Machine Learning: A Case Study with Iohexol Clearance EstimationAlexandre Destere, Pierre Marquet, Charlotte Salmon Gandonnière, et al.
Journal of Clinical Medicine|July 9, 2022
Medications as a Trigger of Sleep-Related Eating Disorder: A Disproportionality AnalysisDiane Merino, Alexandre O Gérard, Elise K Van Obberghen, et al.
Frontiers in Pharmacology|June 7, 2022
COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety DatabaseDiane Merino, Alexandre O Gérard, Elise K Van Obberghen, et al.
Frontiers in Immunology|February 6, 2025
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance databaseAlexandre O Gérard, Diane Merino, Jonathan Benzaquen, et al.
British Journal of Clinical Pharmacology|June 10, 2025
Evaluating and leveraging large language models in clinical pharmacology and therapeutics assessment: From exam takers to exam shapersAlexandre O Gérard, Diane Merino, Marc Labriffe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2025
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With Human Immunodeficiency Virus Type 1: First Results From the ANRS-MIE CARLAPOP StudyNadège Néant, Minh P Lê, Stéphane Bouchet, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected PatientsQuentin Renou, Nadège Néant, Alexandre Destere, et al.
Kidney International Reports|February 5, 2024
Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial IntelligenceAlexandre Destere, Maxime Teisseyre, Diane Merino, et al.
Eclinicalmedicine|July 21, 2025
Maximum cold ischemia duration for a kidney allograft: a prediction model for allograft failure at the time of organ allocationClement Gosset, Susana Barbosa, Alexandre Destere, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|February 9, 2024
An artificial intelligence algorithm for co-clustering to help in pharmacovigilance before and during the COVID-19 pandemicAlexandre Destere, Giulia Marchello, Diane Merino, et al.
Clinical Pharmacokinetics|May 31, 2022
A Hybrid Model Associating Population Pharmacokinetics with Machine Learning: A Case Study with Iohexol Clearance EstimationAlexandre Destere, Pierre Marquet, Charlotte Salmon Gandonnière, et al.
Journal of Clinical Medicine|July 9, 2022
Medications as a Trigger of Sleep-Related Eating Disorder: A Disproportionality AnalysisDiane Merino, Alexandre O Gérard, Elise K Van Obberghen, et al.
Frontiers in Pharmacology|June 7, 2022
COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety DatabaseDiane Merino, Alexandre O Gérard, Elise K Van Obberghen, et al.
Frontiers in Immunology|February 6, 2025
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance databaseAlexandre O Gérard, Diane Merino, Jonathan Benzaquen, et al.
British Journal of Clinical Pharmacology|June 10, 2025
Evaluating and leveraging large language models in clinical pharmacology and therapeutics assessment: From exam takers to exam shapersAlexandre O Gérard, Diane Merino, Marc Labriffe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2025
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With Human Immunodeficiency Virus Type 1: First Results From the ANRS-MIE CARLAPOP StudyNadège Néant, Minh P Lê, Stéphane Bouchet, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected PatientsQuentin Renou, Nadège Néant, Alexandre Destere, et al.
Kidney International Reports|February 5, 2024
Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial IntelligenceAlexandre Destere, Maxime Teisseyre, Diane Merino, et al.
Eclinicalmedicine|July 21, 2025
Maximum cold ischemia duration for a kidney allograft: a prediction model for allograft failure at the time of organ allocationClement Gosset, Susana Barbosa, Alexandre Destere, et al.
Pageof 5